Strive has climbed to about US$22.25 a share, with a mixed return record that includes a rise of 28.7% year to date and a much weaker stretch over several years. Those swings raise a straightforward question for anyone looking at Strive today: Is the current share price still grounded in what the company’s book value suggests the business is worth?
- Over the past 3 years the stock has fallen 31.0%, which puts the focus on whether the balance sheet now tells a different valuation story than the share chart.
- Recent moves to grow a large Bitcoin portfolio and use preferred stock funding can change how investors think about asset mix, capital structure and how much weight to place on book value for Strive.
- Your read on Strive is one view; the desks covering it have another. See what analysts think Strive's shares could be worth.
The issue now is whether Strive’s present market price lines up with what its book value, relative to the industry average, suggests investors are actually paying for.
If you want to stress test this same book value question beyond Strive, you can compare it with a wider pool of ideas drawn from 32 high quality undervalued stocks
Is Strive Still Cheap on Book Value?
P/B fits Strive because the company’s balance sheet and Bitcoin holdings are front and center in how the market is thinking about the business. On this lens, Strive trades on roughly 2.0x P/B compared with a Medical Equipment industry average of about 2.5x and a peer group around 4.9x, so the stock changes hands at a discount to both the sector and similar companies on book value.
Because the Bitcoin accumulation has grabbed attention in recent months, it matters that the current P/B still prices Strive below those benchmarks, which suggests investors are not paying a premium for its equity base despite the enlarged digital asset position. For anyone weighing the shares, the key question is whether that lower multiple reflects concerns about the quality and volatility of those assets or creates room if the balance sheet mix proves more resilient than expected. Explore the numbers behind Strive's P/B valuation.
The Strive Narrative: What Would Justify Today's Price?
Narratives for Strive pick up where the P/B question leaves off and explain what kind of future growth, profitability and earnings would have to occur for today’s share price to look either stretched or conservative. Each scenario links its figures to a clear view on how Strive’s revenue path, margin profile and risk mix could evolve, so you can return to the same framework as new information appears on the Community page.
A written, number driven view on Strive gives you a clear yardstick for how its growing Bitcoin position and preferred stock funding are expected to shape the balance sheet from here. It also creates a simple way to track whether developments like the precision fermented alpha lactalbumin collaboration or the push toward becoming a large corporate crypto holder end up justifying today's valuation assumptions or forcing a rethink.
Share your own Narrative for Strive and set out the assumptions behind your valuation.
Strive’s price is only half the story
Price ratios and balance sheet detail tell you what Strive costs, but the people steering the business and how they are rewarded can heavily shape where it goes next. See who runs Strive and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com